Spirotropane compounds and methods for the modulation of chemokine receptor activity
US8076349B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2005 |
| Grant date | Dec 13, 2011 |
| Priority date | — |
| Expiry date | Jun 13, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds according to formula (I):wherein A, R1 and R2 are as defined herein, and the pharmaceutically acceptable salts, hydrates and solvates thereof are useful for the modulation of CCR5 chemokine receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.